Gut microbiota modulate T cell trafficking into human colorectal cancer

Gut

Volumn 67, Issue 11, 2018, Pages 1984-1994

  Cremonesi, Eleonora ^a   Governa, Valeria ^a   Garzon, Jesus Francisco Glaus ^b   Mele, Valentina ^a   Amicarella, Francesca ^a   Muraro, Manuele Giuseppe ^a   Trella, Emanuele ^a   Galati Fournier, Virginie ^c   Oertli, Daniel ^d   Däster, Silvio Raffael ^d   Droeser, Raoul A ^d   Weixler, Benjamin ^d   Bolli, Martin ^e   Rosso, Raffaele ^f   Nitsche, Ulrich ^g   Khanna, Nina ^a   Egli, Adrian ^a   Keck, Simone ^c   Slotta Huspenina, Julia ^h   Terracciano, Luigi M ^a   Zajac, Paul ^a   Spagnoli, Giulio Cesare ^a   Eppenberger Castori, Serenella ^a   Janssen, Klaus Peter ^g   Borsig, Lubor ^b   Iezzi, Giandomenica ^a   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e St Claraspital AG   (Switzerland)

^f Ospedale Civico Lugano   (Switzerland)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

bacterial translocation; chemokines; colorectal cancer; immune response; T lymphocytes

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE DERIVED CHEMOKINE; RANTES; RNA 16S; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; BIOLOGICAL MARKER; CHEMOKINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM; BACTEROIDES; BINDING AFFINITY; CANCER CELL; CCL11 GENE; CCL13 GENE; CCL17 GENE; CCL27 GENE; CCL7 GENE; CCL8 GENE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SUSPENSION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DESULFOVIBRIO; DOWN REGULATION; FIRMICUTES; FLOW CYTOMETRY; FOXP3 GENE; FRETIBACTERIUM; GENE; GENE CLUSTER; GENE EXPRESSION; HELPER CELL; IMMUNOCOMPETENT CELL; INTESTINE FLORA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; T LYMPHOCYTE; TREPONEMA; ADULT; AGED; ANIMAL; COLORECTAL TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; IN SITU HYBRIDIZATION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS; CELL LINE, TUMOR; CHEMOKINES; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL MICROBIOME; HUMANS; IN SITU HYBRIDIZATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S;

EID: 85048791829     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313498     Document Type: Article

References (28)

1. Fridman WH, Pagès F, Sautès-Fridman C, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306.
2. Pagès F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66.
3. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4.
4. Tosolini M, Kirilovsky A, Mlecnik B, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011;71:1263-71.
5. Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013;39:782-95.
6. Frey DM, Droeser RA, Viehl CT, et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 2010;126:2635-43.
7. Salama P, Phillips M, Grieu F, et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009;27:186-92.
8. Sconocchia G, Eppenberger-Castori S, Zlobec I, et al. HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker. Neoplasia 2014;16:31-42.
9. Amicarella F, Muraro MG, Hirt C, et al. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut 2017;66:692-704.
10. Sconocchia G, Zlobec I, Lugli A, et al. Tumor infiltration by Fc?RIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011;128:2663-72.
11. Droeser RA, Hirt C, Eppenberger-Castori S, et al. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 2013;8:e64814.
12. Governa V, Trella E, Mele V, et al. The interplay between neutrophils and CD8(+) T Cells improves survival in human colorectal cancer. Clin Cancer Res 2017;23:3847-58.
13. Sconocchia G, Eppenberger S, Spagnoli GC, et al. NK cells and T cells cooperate during the clinical course of colorectal cancer. Oncoimmunology 2014;3:e952197.
14. Mlecnik B, Tosolini M, Charoentong P, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 2010;138:1429-40.
15. Hojo S, Koizumi K, Tsuneyama K, et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 2007;67:4725-31.
16. Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012;491:254-8.
17. Céspedes MV, Espina C, García-Cabezas MA, et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 2007;170:1077-85.
18. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
19. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
20. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014;15:317-28.
21. Spranger S, Spaapen RM, Zha Y, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med 2013;5:200ra116.
22. Nagarsheth N, Peng D, Kryczek I, et al. PRC2 epigenetically silences Th1-Type chemokines to suppress effector T-Cell trafficking in colon cancer. Cancer Res 2016;76:275-82.
23. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
24. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/?-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195-206.
25. Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2016;65:1973-80.
26. Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015;42:344-55.
27. Saito T, Nishikawa H, Wada H, et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med 2016;22:679-84.
28. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010;10:131-44.